164 related articles for article (PubMed ID: 22142567)
1. Bone marrow cells: Important role on neovascularization of hepatocellular carcinoma.
Zhu H; Shao Q; Sun X; Deng Z; Yuan X; Zhou X; Ding Y
J Gastroenterol Hepatol; 2012 Jul; 27(7):1241-51. PubMed ID: 22142567
[TBL] [Abstract][Full Text] [Related]
2. Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.
Sun XT; Yuan XW; Zhu HT; Deng ZM; Yu DC; Zhou X; Ding YT
World J Gastroenterol; 2012 Sep; 18(35):4925-33. PubMed ID: 23002366
[TBL] [Abstract][Full Text] [Related]
3. The mobilization, recruitment and contribution of bone marrow-derived endothelial progenitor cells to the tumor neovascularization occur at an early stage and throughout the entire process of hepatocellular carcinoma growth.
Zhu H; Shao Q; Sun X; Deng Z; Yuan X; Yu D; Zhou X; Ding Y
Oncol Rep; 2012 Oct; 28(4):1217-24. PubMed ID: 22858892
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
[TBL] [Abstract][Full Text] [Related]
5. Nicotine promotes contribution of bone marrow-derived cells to experimental choroidal neovascularization in mice.
Hou HY; Wang YS; Xu JF; Wang BR
Exp Eye Res; 2008 Jun; 86(6):983-90. PubMed ID: 18472096
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
7. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
[TBL] [Abstract][Full Text] [Related]
9. Vascular density and VEGF expression in hepatic lesions.
Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
Mise M; Arii S; Higashituji H; Furutani M; Niwano M; Harada T; Ishigami S; Toda Y; Nakayama H; Fukumoto M; Fujita J; Imamura M
Hepatology; 1996 Mar; 23(3):455-64. PubMed ID: 8617424
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth.
Ogawa Y; Suzuki T; Oikawa A; Hosono K; Kubo H; Amano H; Ito Y; Kitasato H; Hayashi I; Kato T; Sugimoto Y; Narumiya S; Watanabe M; Majima M
Biochem Biophys Res Commun; 2009 May; 382(4):720-5. PubMed ID: 19318087
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia promotes vasculogenesis in choroidal neovascularization in diabetic mice by stimulating VEGF and SDF-1 expression in retinal pigment epithelial cells.
Cai Y; Li X; Wang YS; Shi YY; Ye Z; Yang GD; Dou GR; Hou HY; Yang N; Cao XR; Lu ZF
Exp Eye Res; 2014 Jun; 123():87-96. PubMed ID: 24780853
[TBL] [Abstract][Full Text] [Related]
14. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs.
Liu Q; Chen Z; Terry T; McNatt JM; Willerson JT; Zoldhelyi P
Vasc Endovascular Surg; 2009; 43(5):433-43. PubMed ID: 19628514
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
[TBL] [Abstract][Full Text] [Related]
19. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.
Li XM; Tang ZY; Zhou G; Lui YK; Ye SL
J Exp Clin Cancer Res; 1998 Mar; 17(1):13-7. PubMed ID: 9646228
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
